FindTrial
Sign In

Developing an efficient and cost effective method for screening of oral cancer in India

A pilot study to develop an efficacious oral cancer screening strategy for India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017623
Enrollment
30000
Registered
2019-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Tata Trusts
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All healthy individuals aged between 30 to 65 years, with exposure to tobacco, areca nut and alcohol, will be included in the study.

Exclusion criteria

Exclusion criteria: No exclusions, except based on age and tobacco use.

Design outcomes

Primary

MeasureTime frame
a.Develop an effective risk prediction model for identifying high-risk individuals b. To develop a high sensitivity, specificity, high negative reassurance for screen individuals, high positive predictive value for screen positive screening strategy using COE and autofluorescence, with biopsy/histopathology as the gold-standard. Timepoint: a. Development of Risk prediction model- End of year 1 2. Validation of the risk-prediction model- End of year 2—

Secondary

MeasureTime frame
Asses the utility of risk prediction, cytology, and somatic molecular markers for selection of individuals for screening and triage of individuals for biopsy.Timepoint: End of year 2—

Countries

India

Contacts

Public ContactRishav Kanodia

Tata Trusts

umakant@tatatrusts.org9892352563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026